Boston Scientific Corp (MIL:1BSX)
€ 85.5 0 (0%) Market Cap: 126.98 Bil Enterprise Value: 135.61 Bil PE Ratio: 74.26 PB Ratio: 6.39 GF Score: 56/100

Boston Scientific Corp at Stifel Healthcare Conference (Virtual) Transcript

Nov 15, 2021 / 01:00PM GMT
Frederick Allen Wise
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research Analyst

Good morning, everybody, and welcome to the very first meeting of the Stifel Annual Healthcare Conference. Thank you for joining us. I'm particularly pleased to be starting off today's meeting and the conference, in general, with Boston Scientific.

I'd like to very much welcome Dan Brennan, Executive Vice President and Chief Financial Officer; as well as his colleague Lauren Tengler, VP of Investor Relations. Welcome. Good morning. Thanks to you both for being here.

Daniel J. Brennan
Boston Scientific Corporation - Executive VP & CFO

Thanks, Rick. Always a pleasure. Thanks for the invitation.

Frederick Allen Wise;Daniel J.
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research Analyst

Thank you. And, Dan, I know that you are going to start us off this morning with a few high-level words. Thank you. Over to you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot